News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines released in the past hour.
  • Global equity indices showed no significant news-driven movement this hour.
  • No new central bank statements or major economic data were published in the hour.
  • No notable geopolitical incidents or developments reported in the past hour.
  • Commodity and currency markets lacked material news catalysts this hour.
  • No significant corporate earnings, M&A, or corporate actions announced this hour.

Latest Articles

Nano Labs (NA): Deep-Value AI Chip Play with a Path to Re-Rating

Nano Labs (NA): Deep-Value AI Chip Play with a Path to Re-Rating

Nano Labs is a high-throughput and vision-chip designer trading at a sub-$50M market cap. Recent AI infrastructure partnerships and product pushes give a clear rerating route; the company’s cheap multiples, bullish technicals and elevated short interest create an asymmetric risk/reward for a selective long position over a 180-trading-day horizon.

Regeneron: A Rational Long After the Selloff - Why There's Still Upside

Regeneron: A Rational Long After the Selloff - Why There's Still Upside

Regeneron ($REGN) has bounced back from a headline-driven drawdown but the setup remains constructive. At $829.48, the stock trades at ~20x trailing earnings with a free cash flow yield near 4.4% and low leverage. This trade idea outlines an actionable entry, stop, and target with a mid-term horizon, and highlights catalysts and risks tied to pipel…

23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs

23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs

Resmed announces a collaboration with NASCAR driver Tyler Reddick of 23XI Racing to promote sleep apnea awareness. After Tyler's diagnosis with obstructive sleep apnea (OSA) and successful treatment using Resmed's CPAP therapy, he achieved historic victories including three consecutive NASCAR Cup Series wins in 2026. The partnership aims to educate…

Symbotic Joins Stanford Robotics Center Industrial Affiliates Program

Symbotic Joins Stanford Robotics Center Industrial Affiliates Program

Symbotic Inc., a Nasdaq-listed leader in AI-enabled robotics technology for supply chains, has joined the Stanford Robotics Center Industrial Affiliates Program as a member-sponsor. This partnership grants Symbotic access to Stanford's research community and opportunities to collaborate on robotics, autonomy, and AI advancements. The affiliation ai…

Vivakor Raises 2026 Supply & Trading Outlook to $3.5 Billion Amid Expanding Crude Oil Market Opportunities

Vivakor Raises 2026 Supply & Trading Outlook to $3.5 Billion Amid Expanding Crude Oil Market Opportunities

Vivakor has increased its 2026 Supply & Trading outlook to $3.5 billion in annualized commercial activity following significant expansion of its physical crude oil marketing platform. This milestone reflects strong momentum amid volatile global crude oil markets and growing geopolitical uncertainty. The company expects to capitalize on increasing c…

Game Your Game Launches Altus Sports Group Subsidiary to Expand Into Athlete Management, Sports Marketing, Media and Intellectual Property

Game Your Game Launches Altus Sports Group Subsidiary to Expand Into Athlete Management, Sports Marketing, Media and Intellectual Property

Game Your Game, Inc. announced the creation of Altus Sports Group, Inc., a majority-owned subsidiary aimed at expanding beyond golf technology into athlete representation, sports marketing, and media. This strategic expansion leverages the company's AI-powered platform and an experienced UK leadership team to build a comprehensive ecosystem connect…

Euroseas Ltd. Announces 2-Year Charter Contract Extension for its Feeder Containership, M/V Jonathan P

Euroseas Ltd. Announces 2-Year Charter Contract Extension for its Feeder Containership, M/V Jonathan P

Euroseas Ltd. (NASDAQ: ESEA) announced a 2-year extension of the time charter contract for its feeder containership M/V Jonathan P at a daily rate of $26,000 starting October 2026. This extension will generate approximately $12.7 million EBITDA over the minimum contract period and increases charter coverage for 2026 to 2028, reflecting strong deman…

Callan JMB Designates Andy Weigman to Join Callan Power's Oil and Gas Development Efforts; Weigman Brings Experience on More Than $1 Billion in Sourced Acquisition Opportunities and Extensive Williston Basin Operational Expertise

Callan JMB Designates Andy Weigman to Join Callan Power's Oil and Gas Development Efforts; Weigman Brings Experience on More Than $1 Billion in Sourced Acquisition Opportunities and Extensive Williston Basin Operational Expertise

Callan JMB announces the appointment of Andy Weigman as Senior Vice President of Land and Acquisitions at Callan Power, its energy subsidiary. Weigman brings extensive Williston Basin operational and acquisition experience. This move supports Callan Power's strategy to build a diversified non-operated portfolio of oil and gas interests, leveraging …

LPL Financial Welcomes Preferred Financial Group

LPL Financial Welcomes Preferred Financial Group

LPL Financial announced that financial advisors Pat and James Gilbert of Preferred Financial Group have joined LPL's broker-dealer and Registered Investment Advisor platforms, bringing approximately $230 million in assets. The team selected LPL for its scale, technology, and resources to support efficient client service and future growth. This addi…

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers

Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers

Vivos Therapeutics, Inc. reports a 212% increase in new obstructive sleep apnea (OSA) patient referrals at its Nevada Sleep & Airway Medicine Centers over six weeks, alongside the grand opening of a new 8,100 sq. ft. sleep testing and treatment facility in Henderson, Nevada. The company expects this growth and expanded facility to drive further rev…

Satellogic to Meet with Media, Investors, and Partners in New York, Washington, D.C., San Francisco, London, and Paris Ahead of World Space Business Week

Satellogic to Meet with Media, Investors, and Partners in New York, Washington, D.C., San Francisco, London, and Paris Ahead of World Space Business Week

Satellogic Inc. announces a series of in-person meetings across major cities to connect with media, investors, and partners ahead of World Space Business Week in Paris. The company will discuss its Persistent Global Intelligence strategy, highlight recent milestones, and present upcoming developments, including sessions on AI and quantum computing'…

Flux Power to Participate at Upcoming Financial Conferences

Flux Power to Participate at Upcoming Financial Conferences

Flux Power Holdings, Inc., a NASDAQ-listed company specializing in advanced lithium-ion energy storage solutions for industrial and commercial sectors, announced that its CEO and CFO will participate in two notable New York financial conferences in September 2026. The participation aims to engage with investors and analysts and highlight the compan…

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

RenovoRx, Inc. announced publication of pharmacokinetic and pharmacodynamic data from a Phase III TIGeR-PaC clinical trial sub-study, demonstrating their TAMP™ targeted drug-delivery platform delivers approximately 51% of chemotherapy locally in patients with locally advanced pancreatic cancer (LAPC). This method reduces systemic exposure and corre…